{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:15:16Z","timestamp":1732040116413},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,31]]},"DOI":"10.7759\/cureus.12392","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T10:42:02Z","timestamp":1609411322000},"source":"Crossref","is-referenced-by-count":1,"title":["When a Peripartum Cardiomyopathy Patient Hides Various and Serious Risk Factors for Recurrent and Fatal Thromboembolic Events Even Under Well-Conducted Oral Anticoagulation"],"prefix":"10.7759","author":[{"given":"Chaimae","family":"Toutai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oussama","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laachach","family":"Houssam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Elouafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.122s","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg JS","year":"2001","unstructured":"Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001, 119:122S-131S. 10.1378\/chest.119.1_suppl.122s","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2005.11.001","article-title":"Peripartum cardiomyopathy (Article in French)","volume":"55","author":"Fennira S","year":"2006","unstructured":"Fennira S, Demiraj A, Khouaja A, Boujnah MR. Peripartum cardiomyopathy (Article in French). Ann Cardiol Angeiol (Paris). 2006, 55:271-275. 10.1016\/j.ancard.2005.11.001","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.9.1183","article-title":"Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review","volume":"283","author":"Pearson GD","year":"2000","unstructured":"Pearson GD, Veille JC, Rahimtoola S, et al.. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000, 283:1183-1188. 10.1001\/jama.283.9.1183","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa K","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al.. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010, 12:767-778. 10.1093\/eurjhf\/hfq120","journal-title":"Eur J Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.03.014","article-title":"Peripartum cardiomyopathy: a multiple entity (Article in French)","volume":"41","author":"Vanzetto G","year":"2012","unstructured":"Vanzetto G, Martin A, Bouvaist H, Marli\u00e8re S, Durand M, Chavanon O. Peripartum cardiomyopathy: a multiple entity (Article in French). Presse Med. 2012, 41:613-620. 10.1016\/j.lpm.2012.03.014","journal-title":"Presse Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005472","article-title":"Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy","volume":"6","author":"Schelbert EB","year":"2017","unstructured":"Schelbert EB, Elkayam U, Cooper LT, et al.. Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy. J Am Heart Assoc. 2017, 6:e005472. 10.1161\/JAHA.117.005472","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5287","article-title":"Peripartum cardiomyopathy","volume":"364","author":"Honigberg MC","year":"2019","unstructured":"Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019, 364:k5287. 10.1136\/bmj.k5287","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31828155e3","article-title":"Cardiac magnetic resonance imaging in peripartum cardiomyopathy","volume":"347","author":"Arora NP","year":"2014","unstructured":"Arora NP, Mohamad T, Mahajan N, Danrad R, Kottam A, Li T, Afonso LC. Cardiac magnetic resonance imaging in peripartum cardiomyopathy. Am J Med Sci. 2014, 347:112-117. 10.1097\/MAJ.0b013e31828155e3","journal-title":"Am J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study","volume":"3","author":"Kolte D","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, et al.. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014, 3:e001056. 10.1161\/JAHA.114.001056","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2002001400006","article-title":"Pregnancy and peripartum cardiomyopathy. A comparative and prospective study","volume":"79","author":"Avila WS","year":"2002","unstructured":"Avila WS, de Carvalho ME, Tschaen CK, Rossi EG, Grinberg M, Mady C, Ramires JA. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol. 2002, 79:489-493. 10.1590\/s0066-782x2002001400006","journal-title":"Arq Bras Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e31816c446d","article-title":"Peripartum cardiomyopathy presenting with pulmonary embolism: an unusual case","volume":"101","author":"Agunanne E","year":"2008","unstructured":"Agunanne E. Peripartum cardiomyopathy presenting with pulmonary embolism: an unusual case. South Med J. 2008, 101:646-647. 10.1097\/SMJ.0b013e31816c446d","journal-title":"South Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-5-18","article-title":"An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena","volume":"5","author":"Ibebuogu UN","year":"2007","unstructured":"Ibebuogu UN, Thornton JW, Reed GL. An unusual case of peripartum cardiomyopathy manifesting with multiple thrombo-embolic phenomena. Thromb J. 2007, 5:18. 10.1186\/1477-9560-5-18","journal-title":"Thromb J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-200403000-00006","article-title":"Predictors of left ventricular thrombus formation in patients with dilated cardiomyopathy: role of activated protein C resistance","volume":"15","author":"Erbay AR","year":"2004","unstructured":"Erbay AR, Turhan H, Senen K, et al.. Predictors of left ventricular thrombus formation in patients with dilated cardiomyopathy: role of activated protein C resistance. Coron Artery Dis. 2004, 15:107-110. 10.1097\/00019501-200403000-00006","journal-title":"Coron Artery Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3282eff788","article-title":"Treatment of massive cardiac thrombi in a patient with protein C and protein S deficiency","volume":"18","author":"Pa\u00e7 FA","year":"2007","unstructured":"Pa\u00e7 FA, Ca\u011fda\u015f DN. Treatment of massive cardiac thrombi in a patient with protein C and protein S deficiency. Blood Coagul Fibrinolysis. 2007, 18:699-702. 10.1097\/MBC.0b013e3282eff788","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2015.12.058","article-title":"Arterial or venous thrombotic recurrence under anticoagulant treatment, anti-phospholipid syndrome: when should you combine? (Article in French)","volume":"41","author":"Messas E","year":"2016","unstructured":"Messas E. Arterial or venous thrombotic recurrence under anticoagulant treatment, anti-phospholipid syndrome: when should you combine? (Article in French). J Mal Vasc. 2016, 41:105. 10.1016\/j.jmv.2015.12.058","journal-title":"J Mal Vasc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2016.04.302","article-title":"Risk factors for clinicobiological and ultrasound recurrence of venous thromboembolism after a first episode of proximal deep vein thrombosis: results of a prospective study on 195 patients (Article in French)","volume":"37","author":"Lopez M","year":"2016","unstructured":"Lopez M, Desmurs H, Bureau Du Colombier P, Bouchet J, Ninet J, Dargaud Y. Risk factors for clinicobiological and ultrasound recurrence of venous thromboembolism after a first episode of proximal deep vein thrombosis: results of a prospective study on 195 patients (Article in French). Rev Med Interne. 2016, 37:A77-A78. 10.1016\/j.revmed.2016.04.302","journal-title":"Rev Med Interne"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0368-2315(04)96463-0","article-title":"Repeated thromboembolism during pregnancy with constitutional antithrombin deficiency (Article in French)","volume":"33","author":"Schumacker-Blay C","year":"2004","unstructured":"Schumacker-Blay C, Fischer F, Appert A, et al.. Repeated thromboembolism during pregnancy with constitutional antithrombin deficiency (Article in French). J Gynecol Obstet Biol Reprod (Paris). 2004, 33:330-333. 10.1016\/s0368-2315(04)96463-0","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref18","article-title":"NOACS and venous thromboembolic disease: \"translating clinical trials into daily practice\" by an international expert, professor Giancarlo Agnelli (Article in French)","volume":"135","author":"Lambert C","year":"2016","unstructured":"Lambert C. NOACS and venous thromboembolic disease: \"translating clinical trials into daily practice\" by an international expert, professor Giancarlo Agnelli (Article in French). Louvain Med. 2016, 135:344-351.","journal-title":"Louvain Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2017.12.013","article-title":"Place of direct oral anticoagulants in the treatment of thrombophilias and antiphospholipid syndrome (Article in French)","volume":"43","author":"Zuily S","year":"2018","unstructured":"Zuily S. Place of direct oral anticoagulants in the treatment of thrombophilias and antiphospholipid syndrome (Article in French). J M\u00e9decine Vasc. 2018, 43:78. 10.1016\/j.jdmv.2017.12.013","journal-title":"J M\u00e9decine Vasc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1156","article-title":"Anticoagulant treatment with rivaroxaban in severe protein S deficiency","volume":"132","author":"Martinelli I","year":"2013","unstructured":"Martinelli I, Bucciarelli P, Artoni A, Fossali EF, Passamonti SM, Tripodi A, Peyvandi F. Anticoagulant treatment with rivaroxaban in severe protein S deficiency. Pediatrics. 2013, 132:e1435-e1439. 10.1542\/peds.2013-1156","journal-title":"Pediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/46195-when-a-peripartum-cardiomyopathy-patient-hides-various-and-serious-risk-factors-for-recurrent-and-fatal-thromboembolic-events-even-under-well-conducted-oral-anticoagulation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:12Z","timestamp":1707506532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/46195-when-a-peripartum-cardiomyopathy-patient-hides-various-and-serious-risk-factors-for-recurrent-and-fatal-thromboembolic-events-even-under-well-conducted-oral-anticoagulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12392","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}